Literature DB >> 12845499

A single nucleotide polymorphism in the Emp3 gene defines the H4 minor histocompatibility antigen.

Brianna Luedtke1, Laura M Pooler, Eun Young Choi, Angela M Tranchita, Corbett J A Reinbold, Aaron C Brown, Daniel J Shaffer, Derry C Roopenian, Subramaniam Malarkannan.   

Abstract

Minor histocompatibility antigens (minor H antigen) elicit strong T-cell-mediated responses during both graft rejection and graft versus leukemia (GvL) among MHC-matched individuals (where MHC is major histocompatibility complex). Employing expression-cloning methodology, we have identified a cDNA clone, MI-35, encoding the immunodominant H4b minor H antigen within the classical mouse H4 complex. The minimal antigenic epitope derived from H4b presented on Kb class I MHC is SGIVYIHL (SYL8) and the polymorphism is due to C-->T nucleotide modification in p3 resulting in the change of threonine (ACT) to isoleucine (ATT). The results presented here demonstrate that amino acid variation in the allelic epitopes results in the low abundance of H4a peptide. The differential peptide copy number resulted in an immunodominant cytotoxic T cells (CTL) response directed against H4b while the anti-B6 response directed against H4a was easily dominated. These results provide a molecular mechanism for the H4 minor H antigen and suggest a novel mechanism by which alloantigenic disparity caused by conservative amino acid changes can be augmented by posttranslational antigen processing events.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12845499     DOI: 10.1007/s00251-003-0581-x

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  41 in total

1.  Cutting edge: the HLA-A*0101-restricted HY minor histocompatibility antigen originates from DFFRY and contains a cysteinylated cysteine residue as identified by a novel mass spectrometric technique.

Authors:  R A Pierce; E D Field; J M den Haan; J A Caldwell; F M White; J A Marto; W Wang; L M Frost; E Blokland; C Reinhardus; J Shabanowitz; D F Hunt; E Goulmy; V H Engelhard
Journal:  J Immunol       Date:  1999-12-15       Impact factor: 5.422

2.  Distinguishing self from nonself: immunogenicity of the murine H47 locus is determined by a single amino acid substitution in an unusual peptide.

Authors:  L M Mendoza; G Villaflor; P Eden; D Roopenian; N Shastri
Journal:  J Immunol       Date:  2001-04-01       Impact factor: 5.422

3.  An algorithm for the prediction of proteasomal cleavages.

Authors:  C Kuttler; A K Nussbaum; T P Dick; H G Rammensee; H Schild; K P Hadeler
Journal:  J Mol Biol       Date:  2000-05-05       Impact factor: 5.469

4.  PAProC: a prediction algorithm for proteasomal cleavages available on the WWW.

Authors:  A K Nussbaum; C Kuttler; K P Hadeler; H G Rammensee; H Schild
Journal:  Immunogenetics       Date:  2001-03       Impact factor: 2.846

Review 5.  What are minor histocompatibility loci? A new look at an old question.

Authors:  D C Roopenian
Journal:  Immunol Today       Date:  1992-01

Review 6.  Human minor histocompatibility antigens: new concepts for marrow transplantation and adoptive immunotherapy.

Authors:  E Goulmy
Journal:  Immunol Rev       Date:  1997-06       Impact factor: 12.988

7.  Complexity at the mouse minor histocompatibility locus H-4.

Authors:  A P Davis; D C Roopenian
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

Review 8.  Hematopoietic system-specific antigens as targets for cellular immunotherapy of hematological malignancies.

Authors:  Tuna Mutis; Els Goulmy
Journal:  Semin Hematol       Date:  2002-01       Impact factor: 3.851

9.  The model B6(dom1) minor histocompatibility antigen is encoded by a mouse homolog of the yeast STT3 gene.

Authors:  Kevin McBride; Chantal Baron; Serge Picard; Stéphanie Martin; Daniel Boismenu; Alex Bell; John Bergeron; Claude Perreault
Journal:  Immunogenetics       Date:  2002-10-02       Impact factor: 2.846

10.  The original pink-eyed dilution mutation (p) arose in Asiatic mice: implications for the H4 minor histocompatibility antigen, Myod1 regulation and the origin of inbred strains.

Authors:  M H Brilliant; A Ching; Y Nakatsu; E M Eicher
Journal:  Genetics       Date:  1994-09       Impact factor: 4.562

View more
  5 in total

Review 1.  Discovering protective CD8 T cell epitopes--no single immunologic property predicts it!

Authors:  Pavlo Gilchuk; Timothy M Hill; John T Wilson; Sebastian Joyce
Journal:  Curr Opin Immunol       Date:  2015-02-06       Impact factor: 7.486

2.  Distributions of single nucleotide polymorphisms in differential chromosome segments of congenic resistant strains that define minor histocompatibility antigens.

Authors:  Peter J Wettstein; Nancy D Borson
Journal:  Immunogenetics       Date:  2007-05-31       Impact factor: 2.846

3.  Coronary artery disease from isolated non-H2-determined incompatibilities in transplanted mouse hearts.

Authors:  Paul S Russell; Catharine M Chase; Joren C Madsen; Tsutomu Hirohashi; Lynn D Cornell; Thomas J Sproule; Robert B Colvin; Derry C Roopenian
Journal:  Transplantation       Date:  2011-04-27       Impact factor: 4.939

Review 4.  H60: A Unique Murine Hematopoietic Cell-Restricted Minor Histocompatibility Antigen for Graft-versus-Leukemia Effect.

Authors:  Eun Young Choi; Kyungho Choi; Giri Nam; Woojin Kim; Minho Chung
Journal:  Front Immunol       Date:  2020-06-10       Impact factor: 7.561

Review 5.  Know thy immune self and non-self: Proteomics informs on the expanse of self and non-self, and how and where they arise.

Authors:  Sebastian Joyce; Nicola Ternette
Journal:  Proteomics       Date:  2021-08-09       Impact factor: 3.984

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.